Orasis Pharmaceuticals Appoints Jeff Francis as Vice President of Sales and Sam Fakhoury as Vice President of Quality and Operations
Position
Vice President of Operations
Company
Orasis Pharmaceuticals
Ponte Vedra BeachBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
Orasis Pharmaceuticals announced the appointments of Jeff Francis as Vice President of Sales and Sam Fakhoury as Vice President of Quality and Operations. Their combined expertise and leadership will support critical functions in the organization to advance the commercial launch of Qlosi™ (pilocarpine hydrochloride ophthalmic solution) 0.4%, a novel eye drop for the treatment of presbyopia in adults.
Quick answer
Orasis Pharmaceuticals Appoints Jeff Francis as Vice President of Sales and Sam Fakhoury as Vice President of Quality and Operations (October 14, 2024). Orasis Pharmaceuticals is based in Ponte Vedra Beach, Florida, United States.
- Who is the new Vice President of Operations at Orasis Pharmaceuticals?
- Orasis Pharmaceuticals named Sam Fakhoury Vice President of Operations, announced October 14, 2024.
- What did Orasis Pharmaceuticals announce on October 14, 2024?
- Orasis Pharmaceuticals announced the appointments of Jeff Francis as Vice President of Sales and Sam Fakhoury as Vice President of Quality and Operations. Their combined expertise and leadership will support critical functions in the organization to advance the commercial launch of Qlosi™ (pilocarpine hydrochloride ophthalmic solution) 0.4%, a novel eye drop for the treatment of presbyopia in adults.
- What does Orasis Pharmaceuticals do?
- Orasis Pharmaceuticals developed Qlosi, a corrective eye drop for the treatment of presbyopia in adults.
- Where is Orasis Pharmaceuticals based?
- Orasis Pharmaceuticals is based in Ponte Vedra Beach, Florida, United States.
- Which similar companies made leadership changes around the same time?
- Secura Bio (October 15, 2024), Tagworks Pharmaceuticals (October 1, 2024), Alkeus Pharmaceuticals (October 31, 2024) and Acadia Pharmaceuticals (September 23, 2024) also announced leadership changes within 45 days of Orasis Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Secura Bio, Inc. Appoints Charles (Chip) R. Romp as Chief Executive Officer, Succeeding Joseph (Joe) M. Limber (October 15, 2024)
- Tagworks Pharmaceuticals BV Appoints Ken Mills as Chief Executive Officer (October 1, 2024)
- Alkeus Pharmaceuticals Appoints David Arkowitz as Chief Financial Officer (October 31, 2024)
- Catherine Owen Adams Succeeds Steve Davis as CEO at Acadia Pharmaceuticals Inc. (September 23, 2024)
- Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer (November 5, 2024)
- Tarsus Pharmaceuticals Appoints Dr. Elizabeth Yeu, M.D., as Chief Medical Officer (November 5, 2024)
Who to call at Orasis Pharmaceuticals, and when
A new leader at Orasis Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Orasis Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Orasis Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Orasis Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Orasis Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Orasis Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.